Journal Watch · Cell Reports · 2026

STING deficiency does not rescue short telomere-mediated aging phenotypes and longevity in TERC- or TERT-telomerase deficient mice.

Furthermore, they have potential relevance for therapeutic strategies based on STING inhibition in short-telomere-associated age-related diseases in mammalian organisms.

Marión RM, González JC, Flores JM et al.Cell Reports3 min readPharma relevance 40/100

DOI: 10.1016/j.celrep.2026.117786PMID: 42560816Study type: cohort / observational clinical study

TL;DR

Furthermore, they have potential relevance for therapeutic strategies based on STING inhibition in short-telomere-associated age-related diseases in mammalian organisms.

Key findings

  • These findings indicate that STING does not mediate aging phenotypes associated with short telomeres in mammals.
  • Furthermore, they have potential relevance for therapeutic strategies based on STING inhibition in short-telomere-associated age-related diseases in mammalian organisms.

What they did

To address its role in age-related pathologies and decreased longevity associated with short telomeres, we generated double-mutant mice deficient for STING and either the telomerase RNA component (TERC) or the telomerase reverse transcriptase (TERT) component. In both telomerase-deficient mouse cohorts, STING deficiency did not rescue any major phenotypes, including decreased body weight, infertility, multiple degenerative pathologies and, importantly, the progressively decreased maximum and median lifespan of increasing generations of Terc- or Tert-deficient mice.

Full abstract (original)

Background: The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway plays a key role in responding to viral genomes and endogenous DNA byproducts by inducing inflammatory pathways. Its roles in senescence and in the response to telomere shortening have also recently been proposed.

What they did: To address its role in age-related pathologies and decreased longevity associated with short telomeres, we generated double-mutant mice deficient for STING and either the telomerase RNA component (TERC) or the telomerase reverse transcriptase (TERT) component. In both telomerase-deficient mouse cohorts, STING deficiency did not rescue any major phenotypes, including decreased body weight, infertility, multiple degenerative pathologies and, importantly, the progressively decreased maximum and median lifespan of increasing generations of Terc- or Tert-deficient mice.

Results & conclusions: These findings indicate that STING does not mediate aging phenotypes associated with short telomeres in mammals. Furthermore, they have potential relevance for therapeutic strategies based on STING inhibition in short-telomere-associated age-related diseases in mammalian organisms.

Abstract © the authors / Cell Reports (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.celrep.2026.117786 · PubMed 42560816.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking Cell Reports for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Cell Reports study find?

Furthermore, they have potential relevance for therapeutic strategies based on STING inhibition in short-telomere-associated age-related diseases in mammalian organisms.

What type of study is this?

It is a cohort / observational clinical study, published in Cell Reports in 2026. To address its role in age-related pathologies and decreased longevity associated with short telomeres, we generated double-mutant mice deficient for STING and either the telomerase RNA component (TERC) or the telomerase reverse transcriptase (TERT) component.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.celrep.2026.117786. PubMed ID: 42560816. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Marión RM, González JC, Flores JM et al.. STING deficiency does not rescue short telomere-mediated aging phenotypes and longevity in TERC- or TERT-telomerase deficient mice.. Cell Reports (2026). DOI: 10.1016/j.celrep.2026.117786.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/sting-deficiency-does-not-rescue-short-telomere-mediated-aging-phenotype-117786/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides